| Study |
Reference |
|
Boskovic (control unexposed, disease free), 2005
|
Boskovic The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005; 65:807-11
|
|
Boskovic (control unexposed, sick), 2005
|
Boskovic The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005; 65:807-11
|
|
Colvin - IFN beta1b, 2010
|
Colvin Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens. Pharmacoepidemiol Drug Saf 2010; 19:1137-50
|
|
Finkelsztejn (control exposed to Glatiramer), 2011
|
Finkelsztejn The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2011; 113:277-80
|
|
Finkelsztejn (control unexposed, sick), 2011
|
Finkelsztejn The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2011; 113:277-80
|
|
Fragoso a (control exposed to Glatiramer), 2013
|
Fragoso Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review. CNS Drugs 2013; 27:955-61
|
|
Fragoso a (control unexposed, sick), 2013
|
Fragoso Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review. CNS Drugs 2013; 27:955-61
|
|
Fragoso b (control exposed to Glatiramer), 2013
|
Fragoso The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2013; 115:154-9
|
|
Fragoso b (control unexposed, sick), 2013
|
Fragoso The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2013; 115:154-9
|
|
Giannini (control exposed to Glatiramer), 2012
|
Giannini Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol 2012; 12:124
|
|
Giannini (control unexposed, sick), 2012
|
Giannini Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol 2012; 12:124
|
|
Lu (control exposed to Glatiramer), 2012
|
Lu Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult. Scler. 2012; 18:460-7
|
|
Lu (control unexposed, sick), 2012
|
Lu Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult. Scler. 2012; 18:460-7
|
|
Nguyen (control exposed to Glatiramer), 2019
|
Nguyen Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Mult Scler Relat Disord 2019; 28:235-243
|
|
Nguyen (control unexposed, sick), 2019
|
Nguyen Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Mult Scler Relat Disord 2019; 28:235-243
|
|
Portaccio, 2018
|
Portaccio Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. Neurology 2018; 90:e823-e831
|
|
Thiel (control unexposed, sick), 2016
|
Thiel Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Mult. Scler. 2016; 22:801-9
|
|
Weber-Schoendorfer (control exposed to Glatiramer), 2009
|
Weber-Schoendorfer Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult. Scler. 2009; 15:1037-42
|
|
Weber-Schoendorfer (control unexposed, disease free), 2009
|
Weber-Schoendorfer Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult. Scler. 2009; 15:1037-42
|
|
Weber-Schoendorfer (control unexposed, sick), 2009
|
Weber-Schoendorfer Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult. Scler. 2009; 15:1037-42
|
